Medtronic (NYSE:MDT) is gearing up for a pivotal clinical trial of a smartphone-enabled continuous glucose monitor it's developed, according to MobiHealthNews.
The smartphone CGM is designed to connect Medtronic's Guardian glucose monitor with an iOS app for iPhones, Medtronic global program marketing manager Samantha Katz revealed at Health 2.0 in Santa Clara, Calif. the website reported.
"We've heard from our customers that they don't like having to carry a separate display device and they feel self-conscious when they use it in public, so we want to address that," Katz said.
Help employers find you! Check out all the jobs and post your resume.
